tiprankstipranks
Trending News
More News >
Plexus (PLXS)
:PLXS
Advertisement

Plexus (PLXS) AI Stock Analysis

Compare
132 Followers

Top Page

PLXS

Plexus

(NASDAQ:PLXS)

Rating:72Outperform
Price Target:
$138.00
▲(5.72% Upside)
Plexus scores well due to strong financial performance and positive earnings call insights, highlighted by robust cash flow and new program wins. Despite these strengths, technical indicators suggest bearish momentum, and a moderate valuation might deter some investors.
Positive Factors
Financial Performance
Plexus delivered better-than-expected F3Q25 results, with in-line sales and a notable EPS beat, mainly benefited by lower interest expense and a favorable tax adjustment.
Market Share and Demand
PLXS continues to take share, and demand remains strong with new wins with three top semi-cap customers in the quarter, which is expected to support continued outperformance vs the broader industry growth.
Negative Factors
End-market Recovery
End-market recovery tied to industrial and aerospace has not yet materially catalyzed.
Revenue Guidance
F4Q guidance was mixed; while adj-EPS guidance midpoint is slightly above consensus, sales midpoint came in below consensus.

Plexus (PLXS) vs. SPDR S&P 500 ETF (SPY)

Plexus Business Overview & Revenue Model

Company DescriptionPlexus Corp (PLXS) is a leading provider of electronics manufacturing services (EMS). The company operates globally, offering a comprehensive range of product design, supply chain, new product introduction, manufacturing, and aftermarket services to a diverse set of industries, including healthcare, life sciences, industrial, aerospace, defense, and communications. Plexus partners with its customers to provide innovative solutions that meet their unique needs, from concept to completion.
How the Company Makes MoneyPlexus Corp generates revenue primarily through its electronics manufacturing services, which encompass a wide range of activities from design to aftermarket services. The company earns money by providing end-to-end solutions, including product conceptualization, design, prototyping, manufacturing, and supply chain management. Revenue streams are primarily project-based, with contracts negotiated with clients for specific services. Key factors contributing to its earnings include long-term partnerships with clients in high-complexity and regulated industries, which require specialized knowledge and adherence to stringent standards. Additionally, Plexus benefits from economies of scale and operational efficiencies achieved through its global network of manufacturing facilities.

Plexus Earnings Call Summary

Earnings Call Date:Jul 23, 2025
(Q3-2025)
|
% Change Since: -2.47%|
Next Earnings Date:Oct 22, 2025
Earnings Call Sentiment Positive
The earnings call reflected strong financial performance, new business wins, and positive customer sentiment, contributing to a positive outlook. However, challenges in certain sectors, such as Healthcare/Life Sciences and Aerospace, present potential areas of concern.
Q3-2025 Updates
Positive Updates
Strong Revenue and EPS Performance
For the fiscal third quarter, Plexus met its revenue guidance with $1.018 billion and exceeded EPS guidance with a non-GAAP EPS of $1.90, benefiting from strong operating performance and a favorable tax rate.
New Program Wins and Market Expansion
Plexus secured 41 new manufacturing programs worth $250 million annually. These wins were well diversified across market sectors, contributing to future growth prospects.
Recognition as a Top Workplace
Plexus received national and regional recognition as a top workplace, including being listed as one of America's greatest workplaces in manufacturing 2025 by Newsweek.
Strong Cash Flow and Debt Reduction
Plexus generated $13.2 million in free cash flow, reduced debt, and increased share repurchase authorization, positioning the company for long-term shareholder value.
Positive Customer Satisfaction
Plexus achieved a 7-year high in customer satisfaction scores, indicating strong customer sentiment and potential for future market share gains.
Negative Updates
Healthcare/Life Sciences Production Delay
Revenue in the Healthcare/Life Sciences sector was below expectations due to a customer design update that resulted in a temporary production delay.
Challenges in Aerospace Demand
While demand for defense and space subsectors was strong, there was a lack of increased production ramps for Boeing and Airbus, impacting the Aerospace sector.
Inventory Challenges and Cash Cycle
Plexus experienced a 1-day increase in cash cycle days to 69 days, impacted by inventory management and customer advance payments.
Company Guidance
During the Q3 2025 earnings call, Plexus provided optimistic guidance for the upcoming fiscal quarters. Key metrics include a revenue of $1.018 billion for Q3, aligning with their guidance, and a non-GAAP operating margin of 6%, meeting their stated goal. They reported a non-GAAP EPS of $1.90, surpassing expectations, and a free cash flow of $13.2 million, significantly better than anticipated. Looking ahead, Plexus forecasts Q4 revenue between $1.025 billion to $1.065 billion, a non-GAAP operating margin of 5.7% to 6.1%, and EPS of $1.82 to $1.97. They also project approximately $100 million in free cash flow for fiscal 2025, indicating strong cash management and operational efficiency. The company anticipates continued revenue growth through new program ramps, share gains, and strategic investments, with a robust outlook for fiscal 2026 across all market sectors without relying on end-market demand improvements.

Plexus Financial Statement Overview

Summary
Plexus shows strong financial health with stable revenue growth, efficient profitability metrics, low leverage, and excellent cash flow generation. However, there is a slight decline in free cash flow growth that warrants monitoring.
Income Statement
77
Positive
Plexus demonstrates robust revenue levels with a slight growth in revenue of 0.17% in the TTM period compared to the previous year, indicating stability. The company maintains a healthy gross profit margin of 10.1% and a net profit margin of 3.6%, reflecting efficient cost management and profitability. The EBIT margin stands at 5.0%, and the EBITDA margin is 5.9%, showing strong operational efficiency.
Balance Sheet
75
Positive
The balance sheet shows a strong equity position with an equity ratio of 43.8%, suggesting financial stability. The debt-to-equity ratio is 0.19, indicating low leverage which reduces financial risk. Return on Equity for the TTM is 10.6%, reflecting efficient use of equity to generate profits.
Cash Flow
82
Very Positive
Plexus exhibits solid cash flow performance with a significant operating cash flow to net income ratio of 2.84, indicating strong cash-generating capabilities. The free cash flow to net income ratio is 2.35, further emphasizing robust cash flow generation. However, the free cash flow growth rate is slightly negative, showing a minor decline from the previous period.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.96B4.21B3.81B3.37B3.39B
Gross Profit378.53M394.55M347.23M323.30M312.71M
EBITDA236.25M288.55M243.08M240.28M216.17M
Net Income111.81M139.09M138.24M138.91M117.48M
Balance Sheet
Total Assets3.15B3.32B3.39B2.46B2.29B
Cash, Cash Equivalents and Short-Term Investments345.11M256.23M274.81M270.17M385.81M
Total Debt279.59M469.61M495.38M291.32M371.58M
Total Liabilities1.83B2.11B2.30B1.43B1.31B
Stockholders Equity1.32B1.21B1.10B1.03B977.48M
Cash Flow
Free Cash Flow341.32M61.77M-127.85M85.48M160.28M
Operating Cash Flow436.50M165.82M-26.24M142.58M210.37M
Investing Cash Flow-94.95M-93.30M-101.56M-56.97M-49.85M
Financing Cash Flow-255.59M-92.72M139.29M-203.88M-1.46M

Plexus Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price130.53
Price Trends
50DMA
132.60
Negative
100DMA
129.19
Positive
200DMA
139.93
Negative
Market Momentum
MACD
-1.69
Positive
RSI
49.55
Neutral
STOCH
73.02
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For PLXS, the sentiment is Neutral. The current price of 130.53 is below the 20-day moving average (MA) of 131.13, below the 50-day MA of 132.60, and below the 200-day MA of 139.93, indicating a bearish trend. The MACD of -1.69 indicates Positive momentum. The RSI at 49.55 is Neutral, neither overbought nor oversold. The STOCH value of 73.02 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for PLXS.

Plexus Risk Analysis

Plexus disclosed 21 risk factors in its most recent earnings report. Plexus reported the most risks in the "Ability to Sell" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Plexus Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
$0.0025.0611.58%5.87%20.66%
76
Outperform
$0.0049.215.89%14.24%424.78%
74
Outperform
$6.24B52.744.74%1.12%1.34%-38.02%
73
Outperform
$1.40B37.763.49%1.80%-5.95%-43.46%
72
Outperform
$3.69B26.7216.73%14.93%12.89%
72
Outperform
$0.0022.2112.12%2.31%48.63%
62
Neutral
$34.76B5.42-10.49%2.07%6.42%-8.85%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
PLXS
Plexus
130.53
11.48
9.64%
BHE
Benchmark Electronics
39.60
-1.28
-3.13%
LFUS
Littelfuse
251.60
11.78
4.91%
OSIS
OSI Systems
219.64
80.01
57.30%
SANM
Sanmina-Sci
117.05
46.88
66.81%
TTMI
TTM Technologies
43.85
26.11
147.18%

Plexus Corporate Events

Stock Buyback
Plexus Announces New $100 Million Share Buyback
Neutral
May 14, 2025

On May 14, 2025, Plexus Corp.’s Board of Directors approved a new share repurchase program, authorizing the buyback of up to $100 million of its common stock. This will commence after the current $50 million program, which has a remaining balance of $17.9 million as of May 13, 2025, expires. The company has not set a specific schedule for repurchases, indicating flexibility in timing and amount based on market conditions and other factors.

The most recent analyst rating on (PLXS) stock is a Buy with a $140.00 price target. To see the full list of analyst forecasts on Plexus stock, see the PLXS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 29, 2025